Ledger.Open graph →
SEC Form D · filed June 1, 2020

Cardiff Oncology, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Thomas H. Adams · San Diego, CADirectorJohn W. Brancaccio · San Diego, CADirectorJames O. Armitage · San Diego, CADirectorGary W. Pace · San Diego, CADirectorGary S. Jacob · San Diego, CADirectorRodney S. Markin · San Diego, CADirectorLale O. White · San Diego, CADirectorMark S. Erlander · San Diego, CAExecJoseph Schocken · SEATTLE, WADirectorJohn Tomizuka · SEATTLE, WADirectorPeter Huber · Grand Cayman, Cayman IslandsDirectorAlan Spragins · Seattle, WADirectorGanash M. Lokanathen · Senningerberg, LuxembourgExecPaul Kaju · Grand Cayman, Cayman IslandsDirectorIan Muhammad Charoub · Senningerberg, LuxembourgDirectorWilhelmina Steenis · Senningerberg, LuxembourgDirectorRay A. Sturm · San Francisco, CADirectorRobert D. Jennings · Cincinnati, OHDirectorHarry J. Hanchar · Pittsburgh, PADirectorJeremy Powell · Jacksonville, FLDirectorJohn A. Switzer · Charlotte, NCExecDavid A. Mihalick · Charlotte, NCDirectorClarendon H. Masters · Pembroke, BermudaDirectorJin W. Lee · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗